These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32051170)

  • 1. "Is bronchiectasis really a disease?" Michal Shteinberg, Patrick A. Flume and James D. Chalmers.
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32051170
    [No Abstract]   [Full Text] [Related]  

  • 2. "Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline." James D. Chalmers, Megan L. Crichton, Pieter C. Goeminne,
    Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35948349
    [No Abstract]   [Full Text] [Related]  

  • 3. "How can we minimise the use of regular oral corticosteroids in asthma?" Arnaud Bourdin, Ian Adcock, Patrick Berger, Philippe Bonniaud, Philippe Chanson, Cécile Chenivesse, Jacques de Blic, Antoine Deschildre, Philippe Devillier, Gilles Devouassoux, Alain Didier, Gilles Garcia, Antoine Magnan, Yan Martinat, Thierry Perez, Nicolas Roche, Camille Taillé, Pierre Val and Pascal Chanez.
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32051171
    [No Abstract]   [Full Text] [Related]  

  • 4. "Immune mechanisms in fibrotic pulmonary sarcoidosis". P. Weeratunga, D.R. Moller and L-P. Ho.
    Eur Respir Rev; 2023 Sep; 32(169):. PubMed ID: 37611949
    [No Abstract]   [Full Text] [Related]  

  • 5. "Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)." A. Spinou, B. Hererro-Cortina, S. Aliberti,
    Eur Respir J; 2024 Jul; 64(1):. PubMed ID: 39054041
    [No Abstract]   [Full Text] [Related]  

  • 6. "Intersections of lung progenitor cells, lung disease and lung cancer." Carla F. Kim.
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070583
    [No Abstract]   [Full Text] [Related]  

  • 7. "Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis." M.O. Wielpütz and M.A. Mall.
    Eur Respir J; 2024 Apr; 63(4):. PubMed ID: 38636974
    [No Abstract]   [Full Text] [Related]  

  • 8. "Cardiovascular disease and COPD: dangerous liaisons." Klaus F. Rabe, John R. Hurst and Samy Suissa.
    Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30463874
    [No Abstract]   [Full Text] [Related]  

  • 9. "Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis." Bridget F. Collins and Ganesh Raghu.
    Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31722893
    [No Abstract]   [Full Text] [Related]  

  • 10. "The therapy of idiopathic pulmonary fibrosis: what is next?" Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi,
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31554706
    [No Abstract]   [Full Text] [Related]  

  • 11. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang and Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2016 Mar; 25(139):99. PubMed ID: 26929428
    [No Abstract]   [Full Text] [Related]  

  • 12. "Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice." Stephen Y. Chan and Lewis J. Rubin.
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367412
    [No Abstract]   [Full Text] [Related]  

  • 13. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang, Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28049123
    [No Abstract]   [Full Text] [Related]  

  • 14. "Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis." Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58-64.
    Eur Respir Rev; 2015 Sep; 24(137):545. PubMed ID: 26324819
    [No Abstract]   [Full Text] [Related]  

  • 15. "Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis." Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown.
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29653947
    [No Abstract]   [Full Text] [Related]  

  • 16. "Strength of association between comorbidities and asthma: a meta-analysis" Paola Rogliani, Rossella Laitano, Josuel Ora, Richard Beasley and Luigino Calzetta.
    Eur Respir Rev; 2023 Jun; 32(168):. PubMed ID: 37286222
    [No Abstract]   [Full Text] [Related]  

  • 17. "Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis." M. Kolb, B. Crestani and T.M. Maher.
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38537950
    [No Abstract]   [Full Text] [Related]  

  • 18. "Idiopathic inflammatory myopathies and the lung." Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216-238.
    Eur Respir Rev; 2015 Sep; 24(137):545. PubMed ID: 26324818
    [No Abstract]   [Full Text] [Related]  

  • 19. "Malignant pleural effusion: from bench to bedside." Ioannis Psallidas, Ioannis Kalomenidis, Jose M. Porcel, Bruce W. Robinson and Georgios T. Stathopoulos. Eur Respir Rev 2016; 25: 189-198.
    Eur Respir Rev; 2016 Sep; 25(141):360. PubMed ID: 27581834
    [No Abstract]   [Full Text] [Related]  

  • 20. "Advanced medical interventions in pleural disease." Rahul Bhatnagar, John P. Corcoran, Fabien Maldonado, David Feller-Kopman, Julius Janssen, Philippe Astoul and Najib M. Rahman. Eur Respir Rev 2016; 25: 199-213.
    Eur Respir Rev; 2016 Sep; 25(141):360. PubMed ID: 27581835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.